20/25 Logo 5032 (Hydrochlorothiazide and lisinopril 25 mg / 20 mg)
Pill imprint 20/25 Logo 5032 has been identified as Hydrochlorothiazide and lisinopril 25 mg / 20 mg.
Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 25 mg / 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 20/25 Logo 5032
- 25 mg / 20 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|23490-5822||Palmetto State Pharmaceuticals Inc (repackager)|
|16590-0309||Stat RX USA LLC (repackager)|
|43063-0130||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about hydrochlorothiazide/lisinopril
- Hydrochlorothiazide and lisinopril
- Lisinopril and hydrochlorothiazide (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.